Timing matters: the impact of age at CFTR modulator therapy initiation in cystic fibrosis

Authors

• J. Jishu, Tulane University School of Medicine, New Orleans, LA
• E. Toraih, Tulane University School of Medicine, New Orleans, LA
• Humza Malik, LSU Health Sciences Center - New OrleansFollow
• Rahib K. Islam, LSU Health Sciences Center - New OrleansFollow
• Humza A. Pirzadah, LSU Health Sciences Center - New OrleansFollow
• A. Abdelmaksoud, Tulane University School of Medicine, New Orleans, LA
• R. Elshazli, Tulane University School of Medicine, New Orleans, LA
• H. Aiash, SUNY Upstate Medical University, New York, NY
• M. Fawzy, Northern Border University, Arar, Saudi Arabia
• M. Hussein, Tulane University School of Medicine, New Orleans, LA

Document Type

Conference Proceeding

Publication Date

9-1-2025

Publication Title

American Journal of the Medical Sciences

Abstract

2025 Southern Regional Meeting, February 13-15, 2025, New Orleans, LA

First Page

S99

Last Page

S100

Volume

369

Issue

Supplement 1

Comments

Abstract Number: 155

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-No Derivative Works 4.0 International License.

Recommended Citation

Jishu, J.; Toraih, E.; Malik, Humza; Islam, Rahib K.; Pirzadah, Humza A.; Abdelmaksoud, A.; Elshazli, R.; Aiash, H.; Fawzy, M.; and Hussein, M., "Timing matters: the impact of age at CFTR modulator therapy initiation in cystic fibrosis" (2025). School of Medicine Faculty Publications. 4591.
https://digitalscholar.lsuhsc.edu/som_facpubs/4591
10.1016/S0002-9629(25)00164-8